Healthcare Reform: Obama Pushes for Shorter Data Exclusivity Period for...
Many progressives and left-leaning individuals (like me) voted for President Obama because he presented himself as somebody who will stand up for what he believes. Until recently, I, along with others,...
View ArticleWhy Five Years of Data Exclusivity Makes Sense for US Follow-on Biologics...
In case you did not know, the 12 years of market exclusivity proposed for follow-on biologics by supporters and lobbyists for the pharmaceutical and biotechnology industries is part of the impending US...
View ArticleHealthcare Reform Legislation’s Biggest Winners: The Pharmaceutical and...
While I was pleased that President Obama and the Democrats were finally able to deliver much needed reform to an ailing American healthcare system, the compromises that were made to pass the bill are...
View ArticleWhat’s Up With Follow-on Biologics aka Biosimilars?
The conversation about follow-on biologics became extremely muted after passage of the US Healthcare Reform Act which included a 12 year period of data exclusivity for innovator company products. This...
View ArticleMerck Inks a Deal with Sinopharm to Bolster Its Vaccine (and Biosimilar ?)...
Merck & Co today announced that is reached an agreement with Sinopharm Group Co Ltd one of China’s largest biopharmaceutical companies to market its cervical cancer vaccine Gardasil and other...
View ArticleThe BioCon-Pfizer Deal: Pfizer Embraces Biosimilars?
Biocon, one of India’s leading biopharmaceutical companies today announced that they have entered into a strategic global agreement for the worldwide commercialization of Biocon’s biosimilar versions...
View ArticleWhat to Look for From FDA in 2011
The US Food and Drug Administration (FDA) is one of those federal agencies that everyone loves to hate. Sometimes I think the FDA is more vilified than the Internal Revenue Service! Nevertheless, FDA’s...
View ArticleMerck Gets Serious About Biosimilars
Two years ago Merck formed a new division called BioVentures ostensibly to develop and manufacture biosimilar drugs. Interestingly, the announcement preceded creation of a regulatory approval pathway...
View ArticleBusiness Update: Biogen Idec and Samsung Biologics Announce Formation of...
Last December, Biogen Idec and Samsung Biologics (who knew that Samsung makes proteins in addition to TVs and cell phones) announced that they would form a joint venture to develop and manufacture...
View ArticleNew Pharma Magazine to Launch NewPharmaThinkers.com Website
New Pharma Magazine, announced today that it will launch a new website on June 13 called newpharmathinkers.com. According to a press release” “NewPharmaThinkers.com is the new community for big...
View Article
More Pages to Explore .....